The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 20, 2021
Filed:
May. 10, 2018
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
James Aaron Balog, Lambertville, NJ (US);
Emily Charlotte Cherney, Newtown, PA (US);
Liping Zhang, East Windsor, NJ (US);
Audris Huang, New Hope, PA (US);
Weifang Shan, Princeton, NJ (US);
David K. Williams, Delran, NJ (US);
Xiao Zhu, Winchester, MA (US);
Weiwei Guo, Chatham Township, NJ (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 31/444 (2006.01); A61K 31/4709 (2006.01); A61K 31/4375 (2006.01); A61K 31/497 (2006.01); A61K 31/506 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 471/04 (2006.01); C07D 213/85 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07D 213/85 (2013.01); C07D 401/12 (2013.01); C07D 471/04 (2013.01); A61P 35/00 (2018.01);
Abstract
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.